U.S. Court of Appeals for the Federal Circuit
Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA Inc.
This writing
- Type
- Opinion
- Author
- Alan David Lourie
- Filed
- June 25, 2024
- Case
- Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA Inc.
- Case status
- Decided
Source The authoring judge was read from the signature line of the court's own published opinion.
Opening text
The first passage of the document, as extracted by the source provider.
Case: 23-1169 Document: 43 Page: 1 Filed: 06/25/2024 United States Court of Appeals for the Federal Circuit ______________________ AMARIN PHARMA, INC., AMARIN PHARMACEUTICALS IRELAND LIMITED, MOCHIDA PHARMACEUTICAL CO., LTD., Plaintiffs-Appellants v. HIKMA PHARMACEUTICALS USA INC., HIKMA PHARMACEUTICALS PLC, Defendants-Appellees HEALTH NET LLC,…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.